These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 29343523)

  • 1. A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias
    Nguyen HA; Su Y; Zhang JY; Antanasijevic A; Caffrey M; Schalk AM; Liu L; Rondelli D; Oh A; Mahmud DL; Bosland MC; Kajdacsy-Balla A; Peirs S; Lammens T; Mondelaers V; De Moerloose B; Goossens S; Schlicht MJ; Kabirov KK; Lyubimov AV; Merrill BJ; Saunthararajah Y; Van Vlierberghe P; Lavie A
    Cancer Res; 2018 Mar; 78(6):1549-1560. PubMed ID: 29343523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
    Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
    Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity.
    Nguyen HA; Su Y; Lavie A
    J Biol Chem; 2016 Aug; 291(34):17664-76. PubMed ID: 27354283
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Van Trimpont M; Schalk AM; De Visser Y; Nguyen HA; Reunes L; Vandemeulebroecke K; Peeters E; Su Y; Lee H; Lorenzi PL; Chan WK; Mondelaers V; De Moerloose B; Lammens T; Goossens S; Van Vlierberghe P; Lavie A
    Haematologica; 2023 Feb; 108(2):409-419. PubMed ID: 35979719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
    Ghasemi A; Asad S; Kabiri M; Dabirmanesh B
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7227-7238. PubMed ID: 28801829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines.
    Parmentier JH; Maggi M; Tarasco E; Scotti C; Avramis VI; Mittelman SD
    Leuk Res; 2015 Jul; 39(7):757-62. PubMed ID: 25941002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.
    Ln R; Doble M; Rekha VP; Pulicherla KK
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):617-21. PubMed ID: 22042278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.
    Ghasemian A; Al-Marzoqi AH; Al-Abodi HR; Alghanimi YK; Kadhum SA; Shokouhi Mostafavi SK; Fattahi A
    J Cell Physiol; 2019 Nov; 234(11):19271-19279. PubMed ID: 30993718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacterial recombinant L-asparaginases: properties, structure and anti-proliferative activity].
    Sokolov NN; Eldarov MA; Pokrovskaya MV; Aleksandrova SS; Abakumova OY; Podobed OV; Melik-Nubarov NS; Kudryashova EV; Grishin DV; Archakov AI
    Biomed Khim; 2015; 61(3):312-24. PubMed ID: 26215408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-asparaginase-mediated Therapy in L-asparagine Auxotrophic Cancers: A Review.
    Sindhu R; Manonmani HK
    Anticancer Agents Med Chem; 2022; 22(13):2393-2410. PubMed ID: 34994334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asparaginase in the treatment of non-ALL hematologic malignancies.
    Emadi A; Zokaee H; Sausville EA
    Cancer Chemother Pharmacol; 2014 May; 73(5):875-83. PubMed ID: 24515335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
    Ardalan N; Mirzaie S; Sepahi AA; Khavari-Nejad RA
    Med Hypotheses; 2018 Mar; 112():7-17. PubMed ID: 29447943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.
    Avramis VI; Panosyan EH
    Clin Pharmacokinet; 2005; 44(4):367-93. PubMed ID: 15828851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The differential ability of asparagine and glutamine in promoting the closed/active enzyme conformation rationalizes the Wolinella succinogenes L-asparaginase substrate specificity.
    Nguyen HA; Durden DL; Lavie A
    Sci Rep; 2017 Jan; 7():41643. PubMed ID: 28139703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational engineering and insight for a L-glutaminase activity reduced type II L-asparaginase from Bacillus licheniformis and its antileukemic activity in vitro.
    Zhou Y; Shen J; Chi H; Zhu X; Lu Z; Lu F; Zhu P
    Int J Biol Macromol; 2024 Feb; 257(Pt 2):128690. PubMed ID: 38092107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.
    Chan WK; Lorenzi PL; Anishkin A; Purwaha P; Rogers DM; Sukharev S; Rempe SB; Weinstein JN
    Blood; 2014 Jun; 123(23):3596-606. PubMed ID: 24659632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Insight into Substrate Selectivity of Erwinia chrysanthemi L-asparaginase.
    Nguyen HA; Su Y; Lavie A
    Biochemistry; 2016 Mar; 55(8):1246-53. PubMed ID: 26855287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional insights into Erwinia carotovora L-asparaginase.
    Papageorgiou AC; Posypanova GA; Andersson CS; Sokolov NN; Krasotkina J
    FEBS J; 2008 Sep; 275(17):4306-16. PubMed ID: 18647344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the Treatment of Acute Lymphoblastic Leukemia.
    Radadiya A; Zhu W; Coricello A; Alcaro S; Richards NGJ
    Biochemistry; 2020 Sep; 59(35):3193-3200. PubMed ID: 32786406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recombinant intracellular Rhodospirillum rubrum L-asparaginase with low L-glutaminase activity and antiproliferative effect].
    Pokrovskaia MV; Pokrovskiĭ VS; Aleksandrova SS; Anisimova NIu; Adrianov RM; Treshchalina EM; Ponomarev GV; Sokolov NN
    Biomed Khim; 2013; 59(2):192-208. PubMed ID: 23789346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.